
First-Line Cemiplimab + Chemo Improves Outcomes in Advanced NSCLC
Author(s) -
Catlin Nalley
Publication year - 2021
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000802760.29759.7e
Subject(s) - lung cancer , medicine , oncology , chemotherapy , stage (stratigraphy) , progression free survival , paleontology , biology